Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

SMS Turkey: Harnessing the Power of Text Messaging to Promote Smoking Cessation

This study has been completed.
Sponsor:
Collaborator:
Hacettepe University
Information provided by (Responsible Party):
Center for Innovative Public Health Research
ClinicalTrials.gov Identifier:
NCT00912795
First received: May 19, 2009
Last updated: January 31, 2012
Last verified: January 2012
  Purpose

The purpose of this study is to develop and test a text messaging-based smoking cessation program for adults who are currently smoking and want to quit, living in Turkey.


Condition Intervention Phase
Smoking
Behavioral: SMS Turkey
Phase 1

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Official Title: SMS Turkey: Harnessing the Power of TXT Messaging to Promote Smoking Cessation

Resource links provided by NLM:


Further study details as provided by Center for Innovative Public Health Research:

Primary Outcome Measures:
  • 12-week continuous abstinence [ Time Frame: 12-weeks post-quit day ] [ Designated as safety issue: No ]
    self-reported continuous abstinence since quit day (<=5 cigarettes), verified with carbon monoxide reading (<=8ppm)


Enrollment: 151
Study Start Date: January 2009
Study Completion Date: September 2011
Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: SMS Turkey
6-week smoking cessation program delivered via daily text messages
Behavioral: SMS Turkey
6-week smoking cessation program delivered via text messaging
Other Name: Cebiniz birakin diyor
No Intervention: Brochure control
7-page brochure that provided general information and tips on how to quit smoking
Behavioral: SMS Turkey
6-week smoking cessation program delivered via text messaging
Other Name: Cebiniz birakin diyor

Detailed Description:

Smoking has long been recognized as a significant public health concern associated with great morbidity and mortality. Although smoking rates have decreased in high income countries, these trends have not been noted for tow and middle income countries. This is especially true in Turkey, which was ranked 6th in the world in smoking consumption. Between 51-63% of Turkish men and 24-26% of Turkish women 15 years of age and older are smokers. With lung cancer the leading cancer-related cause of death for both men and women, effective and accessible smoking cessation interventions are needed. Cell phone technology represents a unique opportunity to deliver evidenced-based smoking cessation behavioral treatments through a delivery mechanism already widely adopted by adults. An estimated 35 million Turks were using cell phones, making them 1.8 times more common than land lines. Cell phone interventions are a unique delivery method because of their 'always on' capability. The rapid uptake of cell phones allows us to potentially reach those who might otherwise not utilize smoking cessation services.

We propose to design and evaluate an evidenced-based smoking intervention that takes advantage of technologies adopted by adult smokers in Turkey. SMS (Smoking Management System) Turkey will have both wide reach and high impact.

To do so, we bring together a multi-national team of smoking and technology health experts dedicated to building the capacity of smoking cessation research expertise in Turkey to reduce the public health burden associated with smoking in Turkey.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • 18 years of age or older
  • Currently smoking every day
  • Owning a TXT-capable cell phone
  • Sent or received TXT messages at least once in the past year
  • Living in Ankara (to ease technology support if necessary)
  • Agreement to set quit day in 15 days from enrollment date
  • Agreement to verification of smoking cessation using a carbon monoxide breath monitor

Exclusion Criteria:

• No chronic disease.

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00912795

Locations
Turkey
Hacettepe University
Ankara, Turkey
Sponsors and Collaborators
Center for Innovative Public Health Research
Hacettepe University
Investigators
Principal Investigator: Michele Ybarra, MPH PhD Center for Innovative Public Health Research
  More Information

Publications:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Center for Innovative Public Health Research
ClinicalTrials.gov Identifier: NCT00912795     History of Changes
Other Study ID Numbers: ISK-NIH-FIC7918, 5R01TW007918
Study First Received: May 19, 2009
Last Updated: January 31, 2012
Health Authority: United States: Institutional Review Board
Turkey: Ethics Committee

Keywords provided by Center for Innovative Public Health Research:
Smoking Cessation
technology
developing countries

ClinicalTrials.gov processed this record on November 24, 2014